Drugs & medicalClass II

The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major…

Defective container; inadequately sealed blister packaging.

Read the official notice →
Date
2026-03-11
Country
United States
Brand
Harvard Drug Group
Product
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major…
Classification
Class II
Units
Nationwide US.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Harvard Drug Group recalls

  1. 2026-07-01
  2. US
  3. 2026-04-29
  4. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC recalls Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose blister cards) per carton, Rx only, Packaged and…

    Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.

    FDA · DrugThe Harvard Drug Group LLCNationwide in the USAOfficial notice →
  5. 2026-04-22
  6. US
  7. 2025-10-29
  8. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC recalls Gabapentin Capsules, USP, 100 mg, 10 Capsules (10 x 1 blister pack), Rx only, Packaged and Distributed by: Major Pharmaceuticals,…

    Failed Impurities/Degradation Specifications: an out of specification result obtained during routine stability testing for Highest Unknown Impurity .

    FDA · DrugThe Harvard Drug Group LLCUS Nationwide.Official notice →
  9. 2025-07-09
  10. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC recalls Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR…

    Defective container; blister packaging inadequately sealed.

    FDA · DrugThe Harvard Drug Group LLCNationwideOfficial notice →
  11. 2023-07-05
  12. US
    Drugs & medicalClass II

    The Harvard Drug Group recalls Tramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count Tablets Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey…

    Packaging defect: blister packaging inadequately sealed.

    FDA · DrugThe Harvard Drug GroupNationwide in the U.S.Official notice →
All 12 Harvard Drug Group recalls →

Other drugs & medical recalls in the United States

  1. 2026-03-11
  2. US
    Drugs & medicalClass I

    ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

    Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

    FDA · DrugANTHONY TRINH, 123Herbals LLCUSA nationwideOfficial notice →
  3. US
    Drugs & medicalClass II

    HTO Nevada Inc. dba Kirkman recalls FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR…

    Stability Data Does Not Support Expiry Date.

    FDA · DrugHTO Nevada Inc. dba KirkmanNationwide within the U.SOfficial notice →
  4. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc.,…

    Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

    FDA · DrugRising Pharma Holding, Inc.Nationwide within the U.SOfficial notice →
  5. US
    Drugs & medicalClass III

    Cipla USA, Inc. recalls Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for:…

    Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

    FDA · DrugCipla USA, Inc.U.S.A. NationwideOfficial notice →
  6. US
    Drugs & medicalClass II

    Harbin Jixianglong Biotech Co., Ltd. recalls Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC…

    CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

    FDA · DrugHarbin Jixianglong Biotech Co., Ltd.Nationwide within the United StatesOfficial notice →
  7. US
See all drugs & medical recalls →